1. Home
  2. CTMX vs SWVL Comparison

CTMX vs SWVL Comparison

Compare CTMX & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • SWVL
  • Stock Information
  • Founded
  • CTMX 2008
  • SWVL 2017
  • Country
  • CTMX United States
  • SWVL United Arab Emirates
  • Employees
  • CTMX N/A
  • SWVL N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • SWVL Business Services
  • Sector
  • CTMX Health Care
  • SWVL Consumer Discretionary
  • Exchange
  • CTMX Nasdaq
  • SWVL Nasdaq
  • Market Cap
  • CTMX 62.3M
  • SWVL 50.6M
  • IPO Year
  • CTMX 2015
  • SWVL N/A
  • Fundamental
  • Price
  • CTMX $0.59
  • SWVL $3.95
  • Analyst Decision
  • CTMX Buy
  • SWVL
  • Analyst Count
  • CTMX 6
  • SWVL 0
  • Target Price
  • CTMX $5.77
  • SWVL N/A
  • AVG Volume (30 Days)
  • CTMX 3.8M
  • SWVL 10.5K
  • Earning Date
  • CTMX 03-06-2025
  • SWVL 04-29-2025
  • Dividend Yield
  • CTMX N/A
  • SWVL N/A
  • EPS Growth
  • CTMX N/A
  • SWVL N/A
  • EPS
  • CTMX 0.38
  • SWVL N/A
  • Revenue
  • CTMX $138,103,000.00
  • SWVL $19,803,258.00
  • Revenue This Year
  • CTMX N/A
  • SWVL $1,728.00
  • Revenue Next Year
  • CTMX N/A
  • SWVL N/A
  • P/E Ratio
  • CTMX $1.68
  • SWVL N/A
  • Revenue Growth
  • CTMX 36.45
  • SWVL N/A
  • 52 Week Low
  • CTMX $0.56
  • SWVL $2.55
  • 52 Week High
  • CTMX $5.85
  • SWVL $21.94
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 43.41
  • SWVL 38.33
  • Support Level
  • CTMX $0.57
  • SWVL $4.01
  • Resistance Level
  • CTMX $0.65
  • SWVL $4.27
  • Average True Range (ATR)
  • CTMX 0.05
  • SWVL 0.31
  • MACD
  • CTMX 0.01
  • SWVL -0.03
  • Stochastic Oscillator
  • CTMX 51.28
  • SWVL 7.23

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About SWVL Swvl Holdings Corp

Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. Its technology and services provide commuters, travelers and businesses with an alternative to traditional public transportation, taxi companies or other ridesharing companies. The company's core product is B2C Swvl Retail offering, which provides riders with a network of minibuses and other vehicles running on fixed or semi-fixed routes within cities. Commuters use its Swvl mobile application to book rides between pre-defined pick-up points located throughout the city.

Share on Social Networks: